ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 148 filers reported holding ARCUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,997,770 | -12.8% | 222,717 | -1.3% | 1.24% | -0.7% |
Q2 2023 | $4,584,312 | +43.4% | 225,717 | +28.8% | 1.25% | +30.8% |
Q1 2023 | $3,195,958 | +8.7% | 175,217 | +23.2% | 0.96% | +15.7% |
Q4 2022 | $2,941,048 | -37.1% | 142,217 | -20.4% | 0.83% | -34.1% |
Q3 2022 | $4,675,000 | -1.7% | 178,717 | -4.8% | 1.26% | -3.1% |
Q2 2022 | $4,757,000 | +3.8% | 187,717 | +29.3% | 1.30% | +8.6% |
Q1 2022 | $4,583,000 | -3.4% | 145,217 | +23.9% | 1.19% | +0.1% |
Q4 2021 | $4,743,000 | +10.0% | 117,200 | -5.3% | 1.19% | +4.3% |
Q3 2021 | $4,313,000 | +31.2% | 123,700 | +3.3% | 1.14% | +66.5% |
Q2 2021 | $3,287,000 | +103.3% | 119,700 | +107.8% | 0.69% | +78.9% |
Q1 2021 | $1,617,000 | +25.5% | 57,600 | +16.1% | 0.38% | +0.3% |
Q4 2020 | $1,288,000 | +4.2% | 49,600 | -31.2% | 0.38% | -4.7% |
Q3 2020 | $1,236,000 | -30.7% | 72,100 | 0.0% | 0.40% | -21.9% |
Q2 2020 | $1,784,000 | +362.2% | 72,100 | +159.4% | 0.52% | +219.9% |
Q1 2020 | $386,000 | +232.8% | 27,798 | +270.6% | 0.16% | +187.5% |
Q1 2018 | $116,000 | – | 7,500 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |